Anastrozole Recruiting Phase 2 Trials for Hormone Receptor Positive Tumor / Breast Cancer Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03822468Study of 2 Ribociclib Doses in Combination With Aromatase Inhibitors in Women With HR+, HER2- Advanced Breast Cancer
NCT03874325Aromatase Inhibitor and Durvalumab in Postmenopausal Breast Cancer
NCT03839823Study to Compare the Combination of Ribociclib Plus Goserelin Acetate With Hormonal Therapy Versus Combination Chemotherapy in Premenopausal or Perimenopausal Patients With Advanced or Metastatic Breast Cancer
NCT02440230Safety of OFS Combined With AI Endocrine Therapy in Chinese Premenopausal Breast Cancer Patients
NCT02910050Bicalutamide Plus Aromatase Inhibitors in ER(+)/AR(+)/HER2(-) Metastatic Breast Cancer